Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Selective IgG subclass deficiency: quantification and clinical relevance.

R Jefferis¹, D S Kumararatne

¹Division of Immunology, University of Birmingham Medical School, England, UK.

Clinical and Experimental Immunology

|September 1, 1990

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The United Kingdom Primary Immune Deficiency (UKPID) registry 2012 to 2017.

Clinical and experimental immunology·2018

Same author

Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study.

The Journal of allergy and clinical immunology·2016

Same author

Cytolytic activity against mycobacterial antigens: differences between haemophiliacs with and without HIV infection.

Haemophilia : the official journal of the World Federation of Hemophilia·2016

Same author

Familial hepatopulmonary syndrome in common variable immunodeficiency.

Journal of clinical immunology·2015

Same author

More pitfalls in the use of monoclonal antibodies.

Immunology today·2014

Same author

Collaborative study of monoclonal antibodies to human IgG subclasses and allotypes.

Immunology today·2014

Same journal

The many faces of cytokine storm syndrome: immunopathogenic mechanisms and clinical implications for a better patient management.

Clinical and experimental immunology·2026

Same journal

PD-1 Engagement and Circulating Th17 Effector Activity During Secukinumab Treatment in Plaque Psoriasis.

Clinical and experimental immunology·2026

Same journal

Henoch-Schoenlein purpura (HSP) like lesions in IL12RB1 and IL12B defects - A multi-centric experience from India.

Clinical and experimental immunology·2026

Same journal

Case Series on the Efficacy of Daratumumab in Treating Patients with Anti-Interferon-Gamma Autoantibodies.

Clinical and experimental immunology·2026

Same journal

Deleterious germline CARD11 gain-of-function variants alter human B-cell and CD4+ T-cell differentiation and function.

Clinical and experimental immunology·2026

Same journal

Clinical, genetic, and functional characterization of novel NFKB1 variants in Chinese patients with primary immunodeficiency.

Clinical and experimental immunology·2026

See all related articles

Understanding immunoglobulin G (IgG) subclasses is crucial for diagnosing and managing immunodeficiencies. Specific IgG subclass deficiencies, particularly IgG2, can lead to recurrent infections and require targeted clinical evaluation and treatment.

Area of Science:

Immunology
Clinical Medicine

Background:

Human immunoglobulin G (IgG) comprises four subclasses, each with distinct effector functions vital for combating infections.
The immune system's IgG subclass response is antigen-specific, influenced by antigen type, entry route, and presentation.

Purpose of the Study:

To review the biology and clinical significance of IgG subclasses.
To summarize current evidence-based treatment strategies for IgG subclass deficiencies.

Main Methods:

Review of existing literature on IgG subclass function, deficiencies, and clinical management.
Analysis of the relationship between specific antigen responses and IgG subclass production.

Main Results:

Selective IgG subclass deficiencies, especially IgG2, are linked to impaired responses against bacterial carbohydrate antigens.

Related Experiment Videos

Failure to produce appropriate specific IgG antibodies can result in recurrent respiratory tract infections.

Conclusions:

Identifying IgG subclass deficiencies through patient investigation is key for appropriate clinical management.
Understanding IgG subclass biology informs rational therapeutic approaches for immunodeficient patients.